BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38880507)

  • 21. James Lind Alliance Priority Setting Partnership for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM]: An Overview of the Methodology Used to Process and Short-List Research Uncertainties.
    Tetreault L; Mowforth O; Khan DZ; Gronlund T; Garwood P; Hazenbiller O; Harrop JS; Aarabi B; Rahimi-Movaghar V; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Fehlings MG; Davies BM; Kotter MRN;
    Global Spine J; 2022 Feb; 12(1_suppl):19S-27S. PubMed ID: 35174731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance.
    Potter S; Fairhurst K; Cowan K; Vincent S; Lewis I; Cutress RI; Stobart H; Fairbrother P; Turner S; Davies-Crowley K; Jeevan R; Rattay T; O'Connell R; Bundred N; McIntosh SA
    Breast Cancer Res Treat; 2023 Jan; 197(1):39-49. PubMed ID: 36319906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance.
    Peeks F; Boonstra WF; de Baere L; Carøe C; Casswall T; Cohen D; Cowan K; Ferrecchia I; Ferriani A; Gimbert C; Landgren M; Maldonado NL; McMillan J; Nemeth A; Seidita N; Stachelhaus-Theimer U; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2020 Mar; 43(2):279-289. PubMed ID: 31587328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) study.
    Healy P; Galvin S; Williamson PR; Treweek S; Whiting C; Maeso B; Bray C; Brocklehurst P; Moloney MC; Douiri A; Gamble C; Gardner HR; Mitchell D; Stewart D; Jordan J; O'Donnell M; Clarke M; Pavitt SH; Guegan EW; Blatch-Jones A; Smith V; Reay H; Devane D
    Trials; 2018 Mar; 19(1):147. PubMed ID: 29490702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research Priorities for Pediatric Intensive Care Nutrition Within the United Kingdom: A National Institute of Health Research James Lind Alliance Priority Setting Partnership.
    O'Connor G; Marino LV; Tume LN; Stewart A; Gates S; Lanigan J; Bangalore H; Kinsella S
    Crit Care Explor; 2022 Mar; 4(3):e0649. PubMed ID: 35265852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance.
    Mickute G; Staley K; Delaney H; Gardiner O; Hunter A; Keen R; Lockhart L; Meade N; Newman M; Ralston S; Rush E; Upadhyaya S; Regan S; Watts L; Walsh J; White P; Francis RM; Javaid MK
    Orphanet J Rare Dis; 2020 May; 15(1):117. PubMed ID: 32430048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Setting research priorities to improve the health of children and young people with neurodisability: a British Academy of Childhood Disability-James Lind Alliance Research Priority Setting Partnership.
    Morris C; Simkiss D; Busk M; Morris M; Allard A; Denness J; Janssens A; Stimson A; Coghill J; Robinson K; Fenton M; Cowan K
    BMJ Open; 2015 Jan; 5(1):e006233. PubMed ID: 25631309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda.
    Kelly S; Lafortune L; Hart N; Cowan K; Fenton M; Brayne C;
    Age Ageing; 2015 Nov; 44(6):985-93. PubMed ID: 26504119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch.
    Crowe S; Fenton M; Hall M; Cowan K; Chalmers I
    Res Involv Engagem; 2015; 1():2. PubMed ID: 29062491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind Alliance.
    Fernandez MA; Arnel L; Gould J; McGibbon A; Grant R; Bell P; White S; Baxter M; Griffin X; Chesser T; Keene D; Kearney RS; White C; Costa ML
    BMJ Open; 2018 Oct; 8(10):e023301. PubMed ID: 30287674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UK Research Priorities for Electronic Cigarettes: A James Lind Alliance Priority Setting Partnership.
    Hunter A; Ross L; Gronlund T; Cooper S
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
    Brunsdon D; Biesty L; Brocklehurst P; Brueton V; Devane D; Elliott J; Galvin S; Gamble C; Gardner H; Healy P; Hood K; Jordan J; Lanz D; Maeso B; Roberts A; Skene I; Soulsby I; Stewart D; Torgerson D; Treweek S; Whiting C; Wren S; Worrall A; Gillies K
    Trials; 2019 Oct; 20(1):593. PubMed ID: 31615577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What happens after James Lind Alliance Priority Setting Partnerships? A qualitative study of contexts, processes and impacts.
    Staley K; Crowe S; Crocker JC; Madden M; Greenhalgh T
    Res Involv Engagem; 2020; 6():41. PubMed ID: 32670611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research priorities for the management of broken bones of the upper limb in people over 50: a UK priority setting partnership with the James Lind Alliance.
    Sheehan WJ; Williams MA; Paskins Z; Costa ML; Fernandez MA; Gould J; Bell P; Baird L; Grant R; Ellis P; White C; Arnel L; Exell L; Gwilym S
    BMJ Open; 2019 Dec; 9(12):e030028. PubMed ID: 31843820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The James Lind Alliance process approach: scoping review.
    Nygaard A; Halvorsrud L; Linnerud S; Grov EK; Bergland A
    BMJ Open; 2019 Aug; 9(8):e027473. PubMed ID: 31473612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance.
    Ho A; Webster L; Bowen L; Creighton F; Findlay S; Gale C; Green M; Gronlund T; Magee LA; McManus RJ; Mistry HD; Singleton G; Thornton J; Whybrow R; Chappell L
    BMJ Open; 2020 Jul; 10(7):e036347. PubMed ID: 32665388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research priorities in children and adults with congenital heart disease: a James Lind Alliance Priority Setting Partnership.
    Drury NE; Herd CP; Biglino G; Brown KL; Coats L; Cumper MJ; Guerrero RR; Miskin A; Murray S; Pender F; Rooprai S; Simpson JM; Thomson JDR; Weinkauf J; Wootton J; Jones TJ; Cowan K
    Open Heart; 2022 Nov; 9(2):. PubMed ID: 36600635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elbow conditions: research priorities setting in partnership with the James Lind Alliance.
    Singh HP; Chong HH; Raval P; Divall P; Rangan A; Bateman M; Watts A; Phadnis J; Majed A; Jones V; Pandey R; Gower J; Gwilym S; Peach C
    BMJ Open; 2022 Nov; 12(11):e062177. PubMed ID: 36414293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying primary care patient safety research priorities in the UK: a James Lind Alliance Priority Setting Partnership.
    Morris RL; Stocks SJ; Alam R; Taylor S; Rolfe C; Glover SW; Whitcombe J; Campbell SM
    BMJ Open; 2018 Feb; 8(2):e020870. PubMed ID: 29490970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership.
    Staley K; Ahmadi KR; Carter K; Cowan K; Seage H; Visser P; Ward N; Hooper M
    BMJ Open; 2022 Aug; 12(8):e065166. PubMed ID: 36002205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.